For the last year, any discussion of the obesity-drug market has come with an asterisk: Everything will change once pill ...
Add Yahoo as a preferred source to see more of our stories on Google. While there was an explosion in the use of GLP-1 drugs in 2025, two pharmaceutical giants are preparing to debut their oral ...
The launch of the Wegovy pill is being hailed as a turning point in obesity treatment, offering the first tablet version of a drug that has already reshaped the global weight-loss market. Approved ...
Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the ...